ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE

Схожі ресурси

• Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with type 2 diabetes
  за авторством: Bethel, M, та інші
  Опубліковано: (2016)
• SIMPLE AND RATIONAL TWICE-DAILY INSULIN REGIME
  за авторством: Turner, R, та інші
  Опубліковано: (1978)
• Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial
  за авторством: Musiime, V, та інші
  Опубліковано: (2016)
• An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.
  за авторством: Connolly, M, та інші
  Опубліковано: (2009)
• Characteristics of patients needing basal insulin to be given twice-daily or a second insulin formulation during the first year of the 4-T Trial
  за авторством: Levy, J, та інші
  Опубліковано: (2008)